Terms: = Lung cancer AND SOX2, MGC2413, 6657, ENSG00000181449, MCOPS3, P48431, ANOP3 AND Treatment
142 results:
1. WNT5B drives osteosarcoma stemness, chemoresistance and metastasis.
Perkins RS; Murray G; Suthon S; Davis L; Perkins NB; Fletcher L; Bozzi A; Schreiber SL; Lin J; Laxton S; Pillai RR; Wright AJ; Miranda-Carboni GA; Krum SA
Clin Transl Med; 2024 May; 14(5):e1670. PubMed ID: 38689429
[TBL] [Abstract] [Full Text] [Related]
2. RhoGDIβ inhibition via miR-200c/AUF1/sox2/miR-137 axis contributed to lncRNA MEG3 downregulation-mediated malignant transformation of human bronchial epithelial cells.
Yang Y; Tian Z; He L; Meng H; Xie X; Yang Z; Wang X; Zhao Y; Huang C
Mol Carcinog; 2024 May; 63(5):977-990. PubMed ID: 38376344
[TBL] [Abstract] [Full Text] [Related]
3. USP13 drives lung squamous cell carcinoma by switching lung club cell lineage plasticity.
Kwon J; Zhang J; Mok B; Allsup S; Kim C; Toretsky J; Han C
Mol Cancer; 2023 Dec; 22(1):204. PubMed ID: 38093367
[TBL] [Abstract] [Full Text] [Related]
4. Identification of multiple organ metastasis-associated hub mRNA/miRNA signatures in non-small cell lung cancer.
Zu L; He J; Zhou N; Tang Q; Liang M; Xu S
Cell Death Dis; 2023 Dec; 14(12):798. PubMed ID: 38057344
[TBL] [Abstract] [Full Text] [Related]
5. Targeted Proteomic Quantitation of NRF2 Signaling and Predictive Biomarkers in HNSCC.
Wamsley NT; Wilkerson EM; Guan L; LaPak KM; Schrank TP; Holmes BJ; Sprung RW; Gilmore PE; Gerndt SP; Jackson RS; Paniello RC; Pipkorn P; Puram SV; Rich JT; Townsend RR; Zevallos JP; Zolkind P; Le QT; Goldfarb D; Major MB
Mol Cell Proteomics; 2023 Nov; 22(11):100647. PubMed ID: 37716475
[TBL] [Abstract] [Full Text] [Related]
6. Exportin 1 inhibition prevents neuroendocrine transformation through sox2 down-regulation in lung and prostate cancers.
Quintanal-Villalonga A; Durani V; Sabet A; Redin E; Kawasaki K; Shafer M; Karthaus WR; Zaidi S; Zhan YA; Manoj P; Sridhar H; Shah NS; Chow A; Bhanot UK; Linkov I; Asher M; Yu HA; Qiu J; de Stanchina E; Patel RA; Morrissey C; Haffner MC; Koche RP; Sawyers CL; Rudin CM
Sci Transl Med; 2023 Aug; 15(707):eadf7006. PubMed ID: 37531417
[TBL] [Abstract] [Full Text] [Related]
7. Natural Cyclophilin A Inhibitors Suppress the Growth of cancer Stem Cells in Non-Small Cell lung cancer by Disrupting Crosstalk between CypA/CD147 and EGFR.
Han JM; Kim SM; Kim HL; Cho HJ; Jung HJ
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298389
[TBL] [Abstract] [Full Text] [Related]
8. Structural modification of resveratrol analogue exhibits anticancer activity against lung cancer stem cells via suppression of Akt signaling pathway.
Thongsom S; Racha S; Petsri K; Ei ZZ; Visuttijai K; Moriue S; Yokoya M; Chanvorachote P
BMC Complement Med Ther; 2023 Jun; 23(1):183. PubMed ID: 37270520
[TBL] [Abstract] [Full Text] [Related]
9. sox2 Promotes Radioresistance in Non-small Cell lung cancer by Regulating Tumor Cells Dedifferentiation.
Wang S; Li Z; Li P; Li L; Liu Y; Feng Y; Li R; Xia S
Int J Med Sci; 2023; 20(6):781-796. PubMed ID: 37213675
[No Abstract] [Full Text] [Related]
10. Disheveled3 enhanced EMT and cancer stem-like cells properties via Wnt/β-catenin/c-Myc/sox2 pathway in colorectal cancer.
Li Z; Yang Z; Liu W; Zhu W; Yin L; Han Z; Xian Y; Wen J; Tang H; Lin X; Yang Y; Wang J; Zhang K
J Transl Med; 2023 May; 21(1):302. PubMed ID: 37147666
[TBL] [Abstract] [Full Text] [Related]
11. Total flavonoids of Litchi seed attenuate stem cell-like properties in breast cancer by regulating Notch3 signaling pathway.
Liao Y; Luo Z; Liu Y; Xue W; He S; Chen X; Ren H; Yang X; Zhu D; Su Z; Huang Q; Guo H
J Ethnopharmacol; 2023 Apr; 305():116133. PubMed ID: 36603788
[TBL] [Abstract] [Full Text] [Related]
12. Ligand-independent EphA2 contributes to chemoresistance in small-cell lung cancer by enhancing PRMT1-mediated sox2 methylation.
Liang S; Wang Q; Wen Y; Wang Y; Li M; Wang Q; Peng J; Guo L
Cancer Sci; 2023 Mar; 114(3):921-936. PubMed ID: 36377249
[TBL] [Abstract] [Full Text] [Related]
13. Signaling pathways and targeted therapies in lung squamous cell carcinoma: mechanisms and clinical trials.
Niu Z; Jin R; Zhang Y; Li H
Signal Transduct Target Ther; 2022 Oct; 7(1):353. PubMed ID: 36198685
[TBL] [Abstract] [Full Text] [Related]
14. TGFB2-AS1 inhibits triple-negative breast cancer progression via interaction with SMARCA4 and regulating its targets
Zhou C; Wang D; Li J; Wang Q; Wo L; Zhang X; Hu Z; Wang Z; Zhan M; He M; Hu G; Chen X; Shen K; Chen GQ; Zhao Q
Proc Natl Acad Sci U S A; 2022 Sep; 119(39):e2117988119. PubMed ID: 36126099
[TBL] [Abstract] [Full Text] [Related]
15. sox2 regulates paclitaxel resistance of A549 non‑small cell lung cancer cells via promoting transcription of ClC‑3.
Huang Y; Wang X; Hu R; Pan G; Lin X
Oncol Rep; 2022 Oct; 48(4):. PubMed ID: 36069232
[TBL] [Abstract] [Full Text] [Related]
16. The Effect and Mechanism of Curcumin Combined with Carboplatin Chemotherapy Promoting on Apoptosis of lung cancer HCC827 Cells.
Huang L; He X; Zuo X
J Immunol Res; 2022; 2022():1932692. PubMed ID: 35979255
[TBL] [Abstract] [Full Text] [Related]
17. PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma.
Thirusangu P; Ray U; Sarkar Bhattacharya S; Oien DB; Jin L; Staub J; Kannan N; Molina JR; Shridhar V
Oncogene; 2022 Aug; 41(33):4003-4017. PubMed ID: 35804016
[TBL] [Abstract] [Full Text] [Related]
18. PFKFB3 works on the FAK-STAT3-sox2 axis to regulate the stemness in MPM.
Sarkar Bhattacharya S; Thirusangu P; Jin L; Staub J; Shridhar V; Molina JR
Br J Cancer; 2022 Oct; 127(7):1352-1364. PubMed ID: 35794237
[TBL] [Abstract] [Full Text] [Related]
19. lncRNA LUCAT1/ELAVL1/LIN28B/sox2 Positive Feedback Loop Promotes Cell Stemness in Triple-Negative Breast cancer.
Xia L; Wang H
Breast J; 2022; 2022():7689718. PubMed ID: 35711895
[TBL] [Abstract] [Full Text] [Related]
20. Comprehensive Characterization of the Genomic Landscape in Chinese Pulmonary Neuroendocrine Tumors Reveals Prognostic and Therapeutic Markers (CSWOG-1901).
Peng W; Cao L; Chen L; Lin G; Zhu B; Hu X; Lin Y; Zhang S; Jiang M; Wang J; Li J; Li C; Shao L; Du H; Hou T; Chen Z; Xiang J; Pu X; Li J; Xu F; Loong H; Wu L
Oncologist; 2022 Mar; 27(2):e116-e125. PubMed ID: 35641209
[TBL] [Abstract] [Full Text] [Related]
[Next]
